课题基金 / 基金详情

Environmental Factors in HIV Transmission among Suburban IDUs

Environmental Factors in HIV Transmission among Suburban IDUs
郊区注射吸毒者中艾滋病毒传播的环境因素
批准号:
7462387
负责人:
ROBERT HEIMER
金额:
$58.92万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2012-04-30

项目摘要

项目成果

ROBERT HEIMER的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):最近的证据表明,注射毒品的使用正在增加郊区居民。很少有研究关注这一趋势,也没有考虑经济,社会和医疗后果。为了缩小这一差距,我们建议确定,招聘,并研究一个有效的样本注射器谁居住在康涅狄格州郊区使用响应驱动抽样(RDS)。选择RDS是因为它在从隐藏的人群中识别个体和允许对样本进行统计分析方面的优势。我们提交这份申请是为了回应PAR-06-114,“关于环境、行为和艾滋病毒/艾滋病之间联系途径的研究”。不仅将重点放在一个环境-郊区-已被忽视,但我们将进一步关注郊区注射谁注入在两个不同的环境。初步研究表明,有些人主要在其居住的郊区城镇注射,有些人在其获得毒品的城市地区注射。我们的研究是围绕这样一个假设进行的,即两种环境导致以下方面的差异:(1)注射吸毒模式;(2)艾滋病毒、B型肝炎和丙型肝炎感染的知识、风险和患病率;(3)社会人口稳定性;(4)减少注射不良后果的服务的使用和障碍。我们的研究将招募600名居住在郊区的活跃注射毒品使用者的样本。样本将通过结构化访谈,血清学和深入的生活史进行研究。将对样本进行纵向跟踪,以确定郊区或城市注射模式是否稳定,并确定与注射环境变化相关的因素和禽流感病毒感染的风险。我们的研究旨在回答以下问题:(1)样本在潜在人群中的代表性如何,(2)两组不同的郊区注射者是否在疾病知识,风险和患病率方面存在差异,(3)HIV,HBV和HCV的患病率有多少可以通过个人,群体和环境水平变量预测,(4)郊区注射者在地理上如何聚集,这是否影响疾病的流行,(5)与刑事司法系统的互动如何影响药物使用和危险注射做法,(6)哪些因素与逮捕和监禁有关,(7)注射者如何使用药物治疗和疾病预防计划,以及他们认为更大程度地使用这些服务的障碍。为了实现这项研究的目标,我们组建了一个经验丰富的多学科团队,可以收集和分析定量,定性和血清学数据,并通过学术和公共卫生渠道向科学界传播研究成果,并通过我们的艾滋病跨学科研究中心向服务社区传播研究成果。
英文摘要
DESCRIPTION (provided by applicant): Recent evidence suggests that injection drug use is increasing among suburban residents. Little research has focused on this trend, and the economic, social, and medical consequences have not been considered. To close this gap, we are proposing to identify, recruit, and study a valid sample of injectors who reside in Connecticut suburbs using respondent driven sampling (RDS). RDS was selected because of its strengths in identifying individuals from hidden populations and allowing statistical analysis of the sample. We are submitting this application in response to PAR-06-114, "Research on Pathways Linking Environments, Behaviors and HIV/AIDS". Not only will be focusing on an environment - the suburbs - that has been neglected, but we will further focus on suburban injectors who inject in two distinct environments. Preliminary studies revealed that there are those who inject predominantly in the suburban town in which they reside and those who inject in urban areas where they obtain their drugs. We are building our study around the hypothesis that the two environments result in differences in (1) injection drug use patterns; (2) knowledge of, risk for, and prevalence of HIV, hepatitis B, and hepatitis C infections; (3) sociodemographic stability; and (4) the use of and barriers to services that reduce the negative consequences of injection. Our study will recruit a sample of 600 active injection drug users who reside in the suburbs. The sample will be studied through structured interviews, serology, and in-depth life histories. The sample will be followed longitudinally to ascertain whether the pattern of suburban or urban injection is stable and to identify factors associated with changes in injection environments and in risk for syringe-borne viral infection. Our study is designed able to answer questions including (1) how representative the sample is of the underlying population, (2) whether two groups of suburban injectors who differ based on where they inject differ in terms of disease knowledge, risk, and prevalences, (3) how much of the prevalence of HIV, HBV, and HCV can be predicted by individual, group, and environmental level variables, (4) how suburban injectors are geographically clustered and whether this affects disease prevalence, (5) how interaction with the criminal justice system influences drug use and risky injection practices, (6) which factors are associated with arrest and incarceration and (7) how injectors use drug treatment and disease prevention programs and what they perceive as the barriers to larger use of these services. To meet the objectives of this study, we have assembled an experienced, multidisciplinary team that can collect and analyze the quantitative, qualitative, and serological data and disseminate research findings to the scientific community through scholarly and public health channels and to the service community through our Center for Interdisciplinary Research on AIDS.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Addressing Disparities in HIV Testing and Care among Displaced MSM
  • 批准号:
    9349059
  • 项目类别:
  • 资助金额:
    $22.07万
  • 财政年份:
    2017
  • 负责人:
    ROBERT HEIMER
  • 依托单位:
Parenteral HCV Transmission: Assessing Risks and Prevention Strategies in vitro
  • 批准号:
    8774385
  • 项目类别:
  • 资助金额:
    $11.6万
  • 财政年份:
    2014
  • 负责人:
    ROBERT HEIMER
  • 依托单位:
Parenteral HCV Transmission: Assessing Risks and Prevention Strategies in vitro
  • 批准号:
    8326598
  • 项目类别:
  • 资助金额:
    $45.25万
  • 财政年份:
    2011
  • 负责人:
    ROBERT HEIMER
  • 依托单位:
Parenteral HCV Transmission: Assessing Risks and Prevention Strategies in vitro
  • 批准号:
    8487382
  • 项目类别:
  • 资助金额:
    $41.54万
  • 财政年份:
    2011
  • 负责人:
    ROBERT HEIMER
  • 依托单位:
海外基金